Small Cell Lung Cancer
Evergreen Theragnostics Inc. focuses its clinical research on small cell lung cancer, with studies centered on advanced molecular imaging and targeted radiopharmaceutical development.
- Diagnostic imaging
- Radiopharmaceutical therapy
- Oncology biomarker assessment
The sponsor’s research activity includes work with gallium-68-based and lutetium-177-based compounds relevant to tumor visualization and targeted treatment in lung cancer.
Nuclear Medicine and Theranostics
The trial portfolio reflects a strong interest in nuclear medicine approaches that combine diagnostic assessment with targeted therapeutic development for cancer care.
- Molecular imaging
- Targeted radionuclide therapy
- Whole-body distribution analysis
Research activity in this area is directed toward understanding tracer behavior and treatment-related properties in patients with small cell lung cancer.
Oncology Pharmacology
Evergreen Theragnostics Inc. also works in oncology pharmacology, with attention to the safety, tolerability, and pharmacokinetic characteristics of investigational radiolabeled agents.
- Pharmacokinetics
- Safety evaluation
- Tolerability assessment
This area supports the development of precision oncology tools intended for patients with aggressive thoracic malignancies.
